Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

Gilead Sciences (GILD) stock slips as the company agrees to pay $202M to settle allegations that its HIV drug promotion ...

Aurobindo Pharma to manufacture and supply long-acting injectable HIV treatment in 133 countries, offering alternative to ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

In recent months, reports of rising HIV infections in Malaysia have once again made national headlines. The data paints a ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and ...